1-(3,4-dihydroxybenzyl)-N-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxamide

ID: ALA4640803

Chembl Id: CHEMBL4640803

PubChem CID: 156015943

Max Phase: Preclinical

Molecular Formula: C17H14N2O5

Molecular Weight: 326.31

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NO)c1cn(Cc2ccc(O)c(O)c2)c2ccccc2c1=O

Standard InChI:  InChI=1S/C17H14N2O5/c20-14-6-5-10(7-15(14)21)8-19-9-12(17(23)18-24)16(22)11-3-1-2-4-13(11)19/h1-7,9,20-21,24H,8H2,(H,18,23)

Standard InChI Key:  WUWIZMKJYOSVTK-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4640803

    ---

Associated Targets(non-human)

Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1a1 Aldehyde reductase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 326.31Molecular Weight (Monoisotopic): 326.0903AlogP: 1.58#Rotatable Bonds: 3
Polar Surface Area: 111.79Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 8.77CX Basic pKa: 0.12CX LogP: 1.68CX LogD: 1.66
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.33Np Likeness Score: -0.59

References

1. Han Z, Zhu J, Zhang Y, Zhang Y, Zhang H, Qi G, Zhu C, Hao X..  (2020)  Novel quinolin-4(1H)-one derivatives as multi-effective aldose reductase inhibitors for treatment of diabetic complications: Synthesis, biological evaluation, and molecular modeling studies.,  30  (9): [PMID:32192796] [10.1016/j.bmcl.2020.127101]

Source